Pseudohypoparathyroidism Clinical Trial
Official title:
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.
Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03029429 -
Theophylline Treatment for Pseudohypoparathyroidism
|
Phase 2 | |
Recruiting |
NCT04969926 -
Natural History Study of Parathyroid Disorders
|
||
Enrolling by invitation |
NCT04240821 -
Theophylline for Treatment of Pseudohypoparathyroidism
|
Phase 2 | |
Completed |
NCT00004661 -
Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism
|
N/A | |
Recruiting |
NCT05945576 -
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
|
||
Active, not recruiting |
NCT02551120 -
Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
|
||
Recruiting |
NCT04551170 -
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
|
Phase 2 | |
Completed |
NCT00001242 -
Studies of States With Resistance to Vitamin D and Parathyroid Hormone
|
||
Active, not recruiting |
NCT00497484 -
Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
|
N/A |